C532-1741 Screening compound: N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide

C532-1741 Screening compound: N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide
C532-1741 Screening compound: N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C532-1741
N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C532-1741

Molecular Formula

C25H30ClN5O (C25 H30 ClN5 O)

Compound Name

N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide

IUPAC name

N-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]propyl}-3-methyl-1-phenyl-1H-pyrazole-5-carboxamide

SMILES

Cc(cc1C(NCCCN(CC2)CCN2c2c(C)ccc(Cl)c2)=O)nn1-c1ccccc1

InChI

InChI=1S/C25H30ClN5O/c1-19-9-10-21(26)18-23(19)30-15-13-29(14-16-30)12-6-11-27-25(32)24-17-20(2)28-31(24)22-7-4-3-5-8-22/h3-5,7-10,17-18H,6,11-16H2,1-2H3,(H,27,32)

InChI Key

QMSBNHQGBWJGQW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14768185

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.933

Distribution Coefficient, logD

2.786

Water Solubility, LogSw

-4.18

Polar Surface Area

44.336

Acid Dissociation Constant (pKa)

15.87

Base Dissociation Constant (pKb)

8.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

C532-1741 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antimitotic Tubulin Library (17355 compounds)

CNS targets activity set (6557 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C532-1741 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C532-1741?
Check Price and Availability of C532-1741, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C532-1741 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C532-1741
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C532-1741
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C532-1741 available by request